COMPLEX ASSESSMENT OF EFFECTIVENESS OF THE DRUG GROUP ANTIHYPOXANTSIN PATIENTS WITH ANGINA AND HIGH LEVEL ANXIETY

COMPLEX ASSESSMENT OF EFFECTIVENESS OF THE DRUG GROUP ANTIHYPOXANTSIN PATIENTS WITH ANGINA AND HIGH LEVEL ANXIETY

It has been studied the efficiency of ethylmethylhydroxypyridine succinate in patients with angina FC II, depending on the level of anxiety. There was high positive correlation between the number of angina attacks and high level of anxiety in patients with angina FC II. Also, there were some special...

Full description

Bibliographic Details
Main Authors:	G. I. Nechaeva, S. D. Kurochkina, E. V. Semenova, Yu. V. Tereschenko, A. A. Semenkin
Format:	Article
Language:	Russian
Published:	Remedium Group LLC 2017-11-01
Series:	Медицинский совет
Subjects:	ischemic heart disease angina anxiety ethylmethylhydroxypyridine succinate
Online Access:	https://www.med-sovet.pro/jour/article/view/2009

Similar Items

PROTECTION OF BRAIN MITOCHONDRIA AGAINST MICRO STROKE-INDUCED INJURY: A STUDY OF ETHYLMETHYLHYDROXYPYRIDINE SUCCINATE IN EXPERIMENTAL MODEL USING TWO PHOTON LASER FLUORESCENT MICROSCOPY
by: R. A. Afzalov, et al.
Published: (2016-08-01)

EVIDENCE BASE OF ETHYLMETHYLHYDROXYPYRIDINE SUCCINATE USE IN PATIENTS WITH STROKE AND ITS CONSEQUENCES
by: A. D. Ehrlikh, et al.
Published: (2015-09-01)

Effect of mexidol on the efficiency of intravenous thrombolytic therapy for ischemic stroke during the therapeutic window
by: K. S. Knni, et al.
Published: (2018-11-01)

A current view on the prospects for the pharmaceutical therapy in neurorehabilitation after stroke
by: V. N. Shishkova, et al.
Published: (2022-07-01)

Chemoreactome analysis of ethylmethylhydroxypyridine succinate
by: O. A. Gromova, et al.
Published: (2016-11-01)

EFFECT OF THE ETHYLMETHYLHYDROXYPYRIDINE SUCCINATE ON THE OXIDATIVE MODIFICATION OF SERUM PROTEINS IN PATIENTS WITH ISCHEMIC STROKE
by: T. N. Khaybullin, et al.
Published: (2015-12-01)

Acute cerebral circulatory disorders and coronavirus disease
by: N. V. Pizova, et al.
Published: (2020-07-01)

The triple synergy of ethylmethylhydroxypyridine succinate, magnesium, and vitamin B6: Molecular mechanisms
by: O. A. Gromova, et al.
Published: (2017-03-01)

THE EFFECT OF SUBINHIBITORY CONCENTRATIONS OF ETHYLMETHYLHYDROXYPYRIDINE SUCCINATE ON BIOFILMS OF MICROORGANISMS
by: Vazhnichaya E. M., et al.
Published: (2022-03-01)

Influence of propofol on hippocampus in developing brain: an experimental study
by: M. A. Lobov, et al.
Published: (2017-02-01)

Experimental assessment of the toxicity of a cardiac drug based on a phosphodiesterase-3 inhibitor and ethylmethylhydroxypyridine succinate
by: I. S. Varkholiak, et al.
Published: (2022-05-01)

CHANGES IN THE CYTOKINE STATUS WITH STABLE ANGINA
by: E. K. Gordeeva, et al.
Published: (2016-03-01)

Chronic cerebral ischemia and headache in patients in primary care physician's practice
by: V. N. Shishkova, et al.
Published: (2021-02-01)

MODERN PHARMACOTHERAPY OF THE STABLE ANGINA: POSSIBILITIES AND PROSPECTS OF NICORANDIL IMPLEMENTATION
by: Z. M. Sizova, et al.
Published: (2016-01-01)

Chemotranscriptome analysis of the ethylmethylhydroxypyridine succinate molecule in the context of postgenomic pharmacology
by: O. A. Gromova, et al.
Published: (2020-10-01)

Comparison of the association between spiritual experiences and death anxiety in heart failure patients with angina pectoris patients
by: Fatemeh Ghorbani, et al.
Published: (2023-10-01)

CLINICAL EXPERIENCE WITH METABOLIC THERAPY FOR BRAIN ISCHEMIA
by: M. Kh. Shurdumova, et al.
Published: (2014-07-01)

CLINICAL EXPERIENCE WITH METABOLIC THERAPY FOR BRAIN ISCHEMIA
by: M. Kh. Shurdumova, et al.
Published: (2014-07-01)

NEW POSSIBILITIES OF TREATMENT OF PATIENTS WITH ISHEMIC HEART DISEASE AND STABLE ANGINA
by: A. A. SIMAKOV, et al.
Published: (2016-12-01)

THE PROBLEM OF INTERCHANGEABILITY OF DRUG PRODUCTS. TRIMETAZIDINE IS AN EFFECTIVE TREATMENT OF PATIENTS WITH ISCHEMIC HEART DISEASE
by: L. E. Chekuldaeva, et al.
Published: (2015-12-01)

A multimodal approach in the treatment of chronic cerebral ischemia: what should a doctor know?
by: N. V. Pizova
Published: (2020-05-01)

Ethylmethylhydroxypyridine Succinate Is an Inhibitor but Not a Substrate of ABCB1 and SLCO1B1
by: Aleksey V. Shchulkin, et al.
Published: (2023-10-01)

Possibilities of chronic brain ischemia manifestations correction in outpatient practice
by: O. A. Shavlovskaya, et al.
Published: (2021-01-01)

THE ASSESSMENT OF NICORANDIL EFFECT ON THE QUALITY OF LIFE IN PATIENTS WITH STABLE ANGINA IN THE "KVAZAR" STUDY
by: S. Yu. Martsevich, et al.
Published: (2017-01-01)

MexiB 6 AS A RESULT OF FORTIFICATION OF ETHYLMETHYLHYDROXYPYRIDINE SUCCINATE WITH MAGNESIUM AND PYRIDOXINE: PROTEOME EFFECTS
by: O. A. Gromova, et al.
Published: (2016-12-01)

PERCUTANEOUS INTERVENTION IN STABLE ANGINA: WHAT ISSUES DO WE SOLVE?
by: Yu. A. Karpov, et al.
Published: (2018-04-01)

REPORT ON OPEN MULTICENTRAL RESEARCH PROGRAM “PRIORITY” IN CLINICAL PRACTICE. (PEKTROL – QUALITY OF LIFE IN PATIENTS WITH STABLE ANGINA PECTORIS TREATED WITH ISOSORBIDE-5-MONONITRATE IN LONG-ACTING PRESENTATION)
by: Yu. A. Karpov
Published: (2016-01-01)

Safety of Mexidol® (ethylmethylhydroxypyridine succinate) in adult patients of different age groups
by: E. A. Ushkalova, et al.
Published: (2022-10-01)

Non-pharmacological Treatment of Refractory Angina and Microvascular Angina
by: Kudrat Rakhimov, et al.
Published: (2020-08-01)

Does anxiety cause angina recurrence after percutaneous coronary intervention in patients with STEMI?
by: Zhipeng Zhang, et al.
Published: (2023-10-01)

Effect of preinfarction angina on primary percutaneous coronary intervention outcomes
by: Hamid Reza Sanati, et al.
Published: (2018-01-01)

ASSESSMENT OF ADHERENCE TO TREATMENT AND FACTORS AFFECTING IT IN PATIENTS WITH STABLE ISCHEMIC HEART DISEASE DURING THERAPY WITH NICORANDIL
by: S. Yu. Martsevich, et al.
Published: (2017-12-01)

Cardioprotective Effectiveness of a Combination of 2-Ethyl-6-Methyl-3-Hydroxypyridine Enantiomers and Rosuvastatin in a Model of Doxorubicin Cardiomyopathy
by: Pavel D. Kolesnichenko, et al.
Published: (2019-12-01)

EFFICACY AND SAFETY OF METOPROLOL SUCCINATE IN HIGH DOSES IN PATIENTS WITH STABLE COURSE OF ISCHEMIC HEART DISEASE
by: S. N. Tolpygina, et al.
Published: (2016-01-01)

TREATMENT ADHERENCE AND QUALITY OF LIFE OF PATIENTS WITH STABLE ISCHEMIC HEART DISEASE IN TREATMENT WITH NICORANDIL: INTERRELATION AND INTERACTION (ACCORDING TO THE RESULTS OF THE OBSERVATIONAL STUDY NIKEA)
by: S. Yu. Martsevich, et al.
Published: (2018-07-01)

MODERN DRUG THERAPY OF THE CHRONIC STABLE ANGINAE (REVIEW)
by: V. P. Lupanov
Published: (2017-11-01)

Angina de Prinzmetal Angina de Prinzmetal Prinzmetal's angina
by: Eduardo Contreras Zuniga, et al.
Published: (2009-08-01)

Psychophysical rehabilitation aspects of patient with coronary heart disease and Angina.
by: Mohammed Ali Khaleel.
Published: (2012-03-01)

Features of angina development across age groups: data from the World Health Survey (WHS) and the WHO Study on global AGEing and adult health (SAGE)
by: T. M. Maksimova, et al.
Published: (2013-08-01)

Shock wave therapy in cardiology: a commentary
by: S. V. Jargin
Published: (2020-07-01)